SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-22-275845
Filing Date
2022-11-02
Accepted
2022-11-02 16:17:27
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 6-K d312548d6k.htm   iXBRL 6-K 166040
2 EX-99.1 d312548dex991.htm   iXBRL EX-99.1 804306
3 EX-99.2 d312548dex992.htm EX-99.2 101030
  Complete submission text file 0001193125-22-275845.txt   5213550

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mreo-20220630.xsd EX-101.SCH 60912
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mreo-20220630_cal.xml EX-101.CAL 42443
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20220630_def.xml EX-101.DEF 201640
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20220630_lab.xml EX-101.LAB 348150
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20220630_pre.xml EX-101.PRE 293582
62 EXTRACTED XBRL INSTANCE DOCUMENT d312548d6k_htm.xml XML 1009217
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38452 | Film No.: 221354336
SIC: 2834 Pharmaceutical Preparations